The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Glutaminolysis: A Hallmark of Cancer Metabolism
Open accessAbstract
Glutamine is the most abundant circulating amino acid in blood and muscle and is critical for many fundamental cell functions in cancer cells, including synthesis of metabolites that maintain mitochondrial metabolism; generation of antioxidants to remove reactive oxygen species; synthesis of nonessential amino acids (NEAAs), purines, pyrimidines, and fatty acids for cellular replication; and activation of cell signaling. In light of the pleiotropic role of glutamine in cancer cells, a comprehensive understanding of glutamine metabolism is essential for the development of metabolic therapeutic strategies for targeting cancer cells. In this article, we review oncogene-, tumor suppressor–, and tumor microenvironment–mediated regulation of glutamine metabolism in cancer cells. We describe the mechanism of glutamine's regulation of tumor proliferation, metastasis, and global methylation. Furthermore, we highlight the therapeutic potential of glutamine metabolism and emphasize that clinical application of in vivo assessment of glutamine metabolism is critical for identifying new ways to treat patients through glutamine-based metabolic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The breakdown of glutamine through glutaminolysis gives rise to glutamate, a critical precursor of most other nonessential amino acids, including aspartate, alanine, arginine, and proline52.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [52]
In the citing paper
“Glutamine is also a major source of nitrogen for proliferating cells52,54.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [52]
In the citing paper
“In addition to pyruvate-derived acetyl-CoA, α-KG-derived metabolites (e.g., succinate and fumarate) generated via glutaminolysis are considered oncometabolites contributing to tumorigenesis23.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [23]
In the citing paper
“Mitochondrial α-KG can then participate in the TCA cycle, supporting the oxidative phosphorylation (OXPHOS) pathway or the reductive carboxylation pathway23.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 3×
“In order to systematically understand the role of metabolic reprogramming in cancer cells on establishing and maintaining a tumorigenic status, Pavlova & Thompson (2) summarized”
BackgroundAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“As tumors develop, cancer cells recruit nonmalignant stromal cells in their vicinity to form a highly interactive tumor microenvironment (137).”
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
Research works printed but not linked: 8
- Smolke CD, 2010, The Metabolic Pathway Engineering Handbook: Fundamentals
- Matsuno T, 1992, Cancer Res, 52, 1192
- 10.1038/nature12040 · DOI · Paper page
- 10.1016/j.cell.2015.07.016 · DOI · Paper page
- Pizer ES, 1996, Cancer Res, 56, 1189
- Levine B, 2015, J. Clin. Investig., 12514
- Majós C, 2004, Am. J. Neuroradiol., 25, 1696
- 10.1158/1535-7163.MCT-13-0870 · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 860
Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity
Gu, J., Yu, L., Chen, Q., Song, Z., Qian, Q., Liang, Y., Huang, T., Qiao, L., Li, X., Yu, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.034 · Cited by 47
Sun, H.-W., Wu, W., Chen, H., Xu, Y.-T., Yang, Y., Chen, J., Yu, X.-J., Wang, Z., Shuang, Z., & Zheng, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616367 · Cited by 40
Neocortex expansion in development and evolution—from genes to progenitor cell biology
Pinson, A., & Huttner, W. Β. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.04.008 · Cited by 43
Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site
Yoon, N. G., Lee, H., Kim, S.-Y., Hu, S., Kim, D., Yang, S., Hong, K. B., Lee, J. H., Kang, S., Kim, B., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07099 · Cited by 38
Ji, M., Jo, Y., Choi, S. J., Kim, S. M., Kim, K. K., Oh, B., Ryu, D., Paik, M., & Lee, D. H. (2022) · Biomedicines · doi:10.3390/biomedicines10071669 · Cited by 39
Yu, Y., Jiang, Y., Glandorff, C., & Sun, M. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111239 · Cited by 41
Hu, M., Liu, L., & Yao, W. (2018) · Gene · doi:10.1016/j.gene.2018.08.048 · Cited by 39
Metabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C. D., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 39
Li, K., Wei, X., Jiao, X., Deng, W., Li, J., Liang, W., Zhang, Y., & Yang, J. (2023) · Advanced Science · doi:10.1002/advs.202201164 · Cited by 38
Ishibashi, K., Ichinose, T., Kadokawa, R., Mizutani, R., Iwabuchi, S., Togi, S., Ura, H., Tange, S., Shinjo, K., Nakayama, J., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.01.010 · Cited by 40
The Warburg effect: The hacked mitochondrial-nuclear communication in cancer
Jiang, H., & Ye, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.006 · Cited by 40
Metabolic Reprogramming in CD8+ T Cells During Acute Viral Infections
Gupta, S. S., Wang, J., & Chen, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01013 · Cited by 38
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
Ou, J., Xiao, M., Huang, Y., Tu, L., Chen, Z., Cao, S., Wei, Q., & Gu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630791 · Cited by 38
Lee, A. C. K., Lau, P. M., Kwan, Y. W., & Kong, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073315 · Cited by 39
Membrane transporters in cell physiology, cancer metabolism and drug response
Alam, S., Doherty, E., Ortega-Prieto, P., Arizanova, J., & Fets, L. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050404 · Cited by 44
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Zhang, L., Yang, J., Huang, J., Yu, Y., Ding, J., Karges, J., & Xiao, H. (2024) · Chem · doi:10.1016/j.chempr.2023.12.019 · Cited by 38
Ferroptosis in cancer: metabolism, mechanisms and therapeutic prospects
Wu, Y., Li, H., Yue, K., Jing, C., & Duan, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02520-6 · Cited by 44
Dekker, L. J. M., Wu, S., Jurriëns, C., Mustafa, D. A. M., Grevers, F., Burgers, P. C., Smitt, P. A. E. S., Kros, J. M., & Luider, T. M. (2020) · The FASEB Journal · doi:10.1096/fj.201902352r · Cited by 39
Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer
Shah, R., & Chen, S. (2020) · Cancers · doi:10.3390/cancers12092624 · Cited by 36
Tong, Y., Kai, J., Wang, S., Yu, Y., Xie, S., Zheng, H., Wang, Y., Liu, Y., Zhu, K., Guan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03901-7 · Cited by 37
Relationship between metabolic reprogramming and drug resistance in breast cancer
Lv, L., Yang, S., Zhu, Y., Zhai, X., Li, S., Tao, X., & Dong, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.942064 · Cited by 38
Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
Kumar, S., Mittal, S., Gupta, P., Singh, M., Chaluvally–Raghavan, P., & Pradeep, S. (2022) · Cancers · doi:10.3390/cancers14215224 · Cited by 38
The relationship between tumor metabolism and 5-fluorouracil resistance
Hu, J., Li, A., Guo, Y., Ma, T., & Feng, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115902 · Cited by 36
Han, Y., Pu, Y., Liu, X., Liu, Z., Chen, Y., Tang, L., Zhou, J., Song, Q., & Ji, Q. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217186 · Cited by 36
Peroxisomal homeostasis in metabolic diseases and its implication in ferroptosis
Han, J., Zheng, D., Liu, P.-S., Wang, S., & Xie, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01862-w · Cited by 37
Goetting, I., Jendrossek, V., & Matschke, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228563 · Cited by 37
Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells
Shen, Y., Chen, C.-C., Chen, B., Wu, Y.-T., Juan, J.-R., Chen, L.-Y., Teng, Y.-C., & Wei, Y. (2021) · Cells · doi:10.3390/cells10071772 · Cited by 38
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
Xiao, Y., Hu, B., Guo, Y., Zhang, D., Zhao, Y., Chen, Y., Li, N., & Yu, L. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01104-0 · Cited by 35
Li, G., Gong, Z., Dulal, N., Marroquin‐Guzman, M., Rocha, R. O., Richter, M., & Wilson, R. A. (2023) · Nature Communications · doi:10.1038/s41467-023-39880-w · Cited by 35
Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma
Ziki, R. A., & Colnot, S. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101077 · Cited by 36
TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase
Kim, J. H., Lee, J., Cho, Y.-R., Lee, S., Sung, G., Shin, D., Choi, K., & Son, J. (2021) · Cancers · doi:10.3390/cancers13030483 · Cited by 38
Hypoxanthine Induces Muscular ATP Depletion and Fatigue via UCP2
Yin, C., Ma, Z., Li, F., Duan, C., Yuan, Y., Zhu, C., Wang, L., Zhu, X., Wang, S., Gao, P., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.647743 · Cited by 35
Fan, H., Xu, Z., Yao, K., Zheng, B., Zhang, Y., Wang, X., Zhang, T., Li, X., Hu, H., Yue, B., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1443 · Cited by 40
Innate immune response to bone fracture healing
Burgan, J., Rahmati, M., Lee, M., & Saiz, A. M. (2024) · Bone · doi:10.1016/j.bone.2024.117327 · Cited by 38
Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
Grkovski, M., Goel, R., Krebs, S. S., Staton, K. D., Harding, J. J., Mellinghoff, I. K., Humm, J. L., & Dunphy, M. P. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.229740 · Cited by 34
Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer
Ortiz-Pedraza, Y., Muñoz-Bello, J. O., Olmedo‐Nieva, L., Contreras‐Paredes, A., Martínez-Ramírez, I., Langley, E., & Lizano, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082872 · Cited by 34
Extracellular vesicles in metabolic perspective: mechanism and targeted therapy
Sheng, Q., Wu, Z., Li, W., Wang, L., Xu, H., Wang, W., Yan, Z., Ge, G., Xu, Y., & Geng, D. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03763-7 · Cited by 36
Normal and Neoplastic Growth Suppression by the Extended Myc Network
Wang, H., & Prochownik, E. (2022) · Cells · doi:10.3390/cells11040747 · Cited by 31
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
Uchinomiya, S., Nagaura, T., Weber, M., Matsuo, Y., Zenmyo, N., Yoshida, Y., Tsuruta, A., Koyanagi, S., Ohdo, S., Matsunaga, N., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02043 · Cited by 33
Ielpo, S., Barberini, F., Moghaddam, F. D., Pesce, S., Cencioni, C., Spallotta, F., Ninno, A. D., Businaro, L., Marcenaro, E., Bei, R., et al. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102843 · Cited by 34
Multi-omics reveals immune response and metabolic profiles during high-altitude mountaineering
Yin, J., Lv, J., Yang, S., Wang, Y., Huang, Z., Wang, X., Hou, G., Zhou, W., Liu, Y., Wang, W., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115134 · Cited by 36
The regulation of cell metabolism by hypoxia and hypercapnia
Reddan, B., & Cummins, E. P. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108252 · Cited by 34
García‐Cañaveras, J. C., & Lahoz, A. (2021) · Cancers · doi:10.3390/cancers13133230 · Cited by 34
MicroRNAs as Regulators of Cancer Cell Energy Metabolism
Natarajaseenivasan, S. M., Velusamy, P., Mercy, C. S. A., Langford, D., Natarajaseenivasan, K., & Shanmughapriya, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081329 · Cited by 35
Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications
Zeković, M., Bumbaširević, U., Živković, M., & Pejcic, T. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021391 · Cited by 31
Metabolic Reprogramming in Thyroid Cancer
Ju, S. H., Song, M., Lim, J. Y., Kang, Y. E., Yi, H., & Shong, M. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1802 · Cited by 37
Xing, Y., & Liu, C. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02683-7 · Cited by 32
The metabolic landscape of urological cancers: New therapeutic perspectives
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., Baltazar, F., & Jerónimo, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.034 · Cited by 33
Yoshida, G. J. (2021) · Metabolites · doi:10.3390/metabo11010027 · Cited by 32
Yu, J., Chen, X., Li, J., & Wang, F. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13540 · Cited by 31
Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib
Liu, Y., Ge, X., Pang, J., Zhang, Y., Zhang, H., Wu, H., Fan, F., & Liu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671328 · Cited by 31
Bonomini, M., Masola, V., Procino, G., Zammit, V. A., Divino‐Filho, J. C., Arduini, A., & Gambaro, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157955 · Cited by 32
Monitoring and modelling the glutamine metabolic pathway: a review and future perspectives
Mirveis, Z., Howe, O. L., Cahill, P. A., Patil, N., & Byrne, H. J. (2023) · Metabolomics · doi:10.1007/s11306-023-02031-9 · Cited by 35
Mitochondrial Dysfunction and Metabolic Disturbances Induced by Viral Infections
Pérez, S., Gooz, M. B., & Maldonado, E. N. (2024) · Cells · doi:10.3390/cells13211789 · Cited by 32
Huang, X., Xia, K., Wei, Z., Liu, W., Wei, Z., & Guo, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05803-6 · Cited by 31
Lactylation in cancer biology: Unlocking new avenues for research and therapy
Hou, X., Hong, Z., Zeng, H., Zhang, C., Zhang, P., Ma, D., & Han, Z. (2025) · 癌症:英文版 · doi:10.1002/cac2.70054 · Cited by 39
Soumoy, L., Schepkens, C., Krayem, M., Najem, A., Tagliatti, V., Ghanem, G., Saussez, S., Colet, J., & Journé, F. (2020) · Cancers · doi:10.3390/cancers12051323 · Cited by 30
Bazer, F. W., Seo, H., Johnson, G. A., & Wu, G. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-54462-1_1 · Cited by 31
Bian, Y., Yin, G., Wang, G., Liu, T., Liang, L., Yang, X., Zhang, W., & Tang, D. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09681-2 · Cited by 30
Drug delivery for metabolism targeted cancer immunotherapy
Khodaei, T., Inamdar, S., Suresh, A. P., & Acharya, A. P. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114242 · Cited by 30
Guo, L.-J., Chen, S., Ou, L., Li, S., Ye, Z.-N., & Liu, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369090 · Cited by 34
Metaboloepigenetics in cancer, immunity, and cardiovascular disease
Keating, S. T., & El‐Osta, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac058 · Cited by 29
Shin, E., Kim, B., Kang, H., Lee, H., Park, J., Kang, J., Park, E., Jo, S., Kim, H. Y., Lee, J. S., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127511 · Cited by 29
Targeting 2-oxoglutarate dehydrogenase for cancer treatment.
Chang, L., Chiang, S.-K., Chen, S., & Hung, M. (2022) · PubMed Central · Cited by 29
Shannar, A., Sarwar, M. S., & Kong, A. T. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.4.335 · Cited by 29
Xiao, S., Zhang, S., Sun, K., Huang, Q., Li, Q., & Hu, C. (2025) · Biomarker Research · doi:10.1186/s40364-025-00849-0 · Cited by 31
Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts
Wang, H., Lu, J. L., Kulkarni, S., Zhang, W., Gorka, J. E., Mandel, J. A., Goetzman, E. S., & Prochownik, E. V. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005200 · Cited by 29
Ishikawa, K., Hosoi, Y., Tanaka, H., Jiang, L., Toyokuni, S., Nakamura, K., Kajiyama, H., Kikkawa, F., Mizuno, M., & Hori, M. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108414 · Cited by 28
Circular RNA circNHSL1 Contributes to Gastric Cancer Progression Through the miR-149-5p/YWHAZ Axis
Hui, C., Tian, L., & He, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s253152 · Cited by 28
Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges
Yang, Y., Deng, X., Li, Q., Wang, F., Miao, L., & Jiang, Q. (2020) · 癌症:英文版 · doi:10.1002/cac2.12109 · Cited by 26
More Than Meets the Eye Regarding Cancer Metabolism
Kubicka, A., Matczak, K., & Łabieniec-Watała, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179507 · Cited by 31
Zhou, Y.-J., Yu, H., Cheng, S., Chen, Y., He, L., Ren, J., He, X. Q., Chen, J., Zheng, L., Li, F., et al. (2022) · Journal of Cancer · doi:10.7150/jca.64195 · Cited by 28
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
Meng, W., Palmer, J. D., Siedow, M. R., Haque, S. J., & Chakravarti, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042246 · Cited by 34
Kusum, K., Raj, R., Rai, S., Pranjali, P., Ashish, A., Vicente-Muñoz, S., Chaube, R., & Kumar, D. (2022) · ACS Omega · doi:10.1021/acsomega.2c00332 · Cited by 29
The interplay of the circadian clock and metabolic tumorigenesis
Wang, Z., Ma, L., Meng, Y., Fang, J., Xu, D., & Lu, Z. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.11.004 · Cited by 31
Jakobsen, S., & Nielsen, C. U. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020197 · Cited by 28
Glutaminolysis inhibition boosts photodynamic therapy to eliminate cancer stem cells
Wang, Q., Li, S., Xu, C., Wang, X., Yang, T., Wang, C., Xiong, Y., Zhang, Z., Yang, X., & Li, Z. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122497 · Cited by 27
Xing, L., Gkini, V., Nieminen, A. I., Zhou, H.-C., Aquilino, M., Naumann, R., Reppe, K., Tanaka, K., Carmeliet, P., Heikinheimo, O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47437-8 · Cited by 32
Regulatory mechanisms of amino acids in ferroptosis
Yao, H., Jiang, W., Liao, X., Wang, D., & Zhu, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122803 · Cited by 29
Shi, X., Zhang, Y., Wang, Y., Wang, J., Gao, Y., Wang, R., Wang, L., Xiong, M., Cao, Y., Ou, N., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01323-4 · Cited by 27
Wu, H., Li, J., Yao, R., Liu, J., Su, L., & You, W. (2025) · Theranostics · doi:10.7150/thno.113727 · Cited by 30
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01173 · Cited by 29
Glutamine regulates ovarian cancer cell migration and invasion through ETS1
Prasad, P., & Roy, S. S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07064 · Cited by 27
Metabolic features of innate lymphoid cells
Yu, H., Jacquelot, N., & Belz, G. T. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221140 · Cited by 31
Olivas-Aguirre, M., Pérez-Chávez, J., Torres-López, L., Hernández‐Cruz, A., Pottosin, I. I., & Dobrovinskaya, O. R. (2023) · Cancers · doi:10.3390/cancers15020445 · Cited by 29
Targeting the Metabolic Paradigms in Cancer and Diabetes
Bosso, M., Haddad, D., Madhoun, A. S. A., & Al‐Mulla, F. (2024) · Biomedicines · doi:10.3390/biomedicines12010211 · Cited by 26
Muranaka, H., Akinsola, R., Billet, S., Pandol, S. J., Hendifar, A. E., Bhowmick, N. A., & Gong, J. (2024) · Cancers · doi:10.3390/cancers16051057 · Cited by 27
Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
Lin, L., Ren, R., Xiong, Q., Zheng, C., Yang, B., & Wang, H. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103583 · Cited by 28
High-Performance Metabolic Profiling of High-Risk Thyroid Nodules by ZrMOF Hybrids
Chen, J., Yu, X., Qu, Y., Wang, X., Wang, Y., Jia, K. J., Du, Q., Han, J., Liu, H., Zhang, X., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c05700 · Cited by 26
Chen, S., Jiang, Y. L., Zheng, J., Li, P., Liu, M., Zhu, Y., Zhu, S., & Chang, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.073 · Cited by 26
Angione, C. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx562 · Cited by 29
Li, L., Peng, G., Liu, X., Zhang, Y., Han, H., & Liu, Z. (2020) · iScience · doi:10.1016/j.isci.2020.101684 · Cited by 27
Feng, M., Fei, S., Xia, J., Zhang, M., Wu, H., Swevers, L., & Sun, J. (2021) · Viruses · doi:10.3390/v13050841 · Cited by 26
Barreca, F., Aventaggiato, M., Vitiello, L., Sansone, L., Russo, M. A., Mai, A., Valente, S., & Tafani, M. (2023) · Antioxidants · doi:10.3390/antiox12081635 · Cited by 24
Solsona, B. G., Horn, H., Schmitt, A., Xu, W., Bucher, P., Heinrich, A., Kalmbach, S., Kreienkamp, N., Franke, M., Wimmers, F., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010964 · Cited by 26
Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy
Zhao, Z., Cao, Y., Xu, R. F., Fang, J., Zhang, Y., Xu, X., Huang, L., & Li, R. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.03.003 · Cited by 27
The solid tumor microenvironment and related targeting strategies: a concise review
Wang, Y., Zhou, H., Ju, S., Dong, X., & Zheng, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563858 · Cited by 35
Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome
Wang, Y., Wu, J., Zhang, G., Shi, Y., Meng, Y., Lv, P., Huang, W., Su, Y., Zhou, Z., Wang, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62951-z · Cited by 28
From Prokaryotes to Cancer: Glutamine Flux in Multicellular Units
Erez, A., & Kolodkin‐Gal, I. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.05.007 · Cited by 26
Metadata
- Authors
- Yang, L., Venneti, S., & Nagrath, D.
- Affiliations
- Rice University (US)
- University of Michigan (US)
- Venue
- Annual Review of Biomedical Engineering
- Publisher
- Annual Reviews
- Published
- 2017-06-21
- Volume
- 19
- Issue
- 1
- Pages
- 163-194
- ISSN
- 1523-9829 (ISSN-L)
- 1545-4274
- OpenAlex
- W2534904302
- Cited by
- 859
- References
- 171
- Citations by year
- 2026: 68 · 2025: 140 · 2024: 137 · 2023: 132 · 2022: 126 · 2021: 98 · 2020: 71 · 2019: 46 · 2018: 28 · 2017: 13
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Rice Research Repository (Rice University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- glutamine metabolism, glutaminolysis, cancer metabolism, tumor microenvironment, oncogenes, tumor suppressor, metastasis, global DNA methylation, tumor cell proliferation, metabolic therapy, reactive oxygen species, purine and pyrimidine synthesis, signal transduction
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Glutamine, Humans, Mitochondria, Models, Biological, Neoplasms, Biomarkers, Tumor, Signal Transduction, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review